💊 GLP-1 Drugs
Mounjaro vs Ozempic — Which Is More Effective for Weight Loss? (2026)
Mounjaro (tirzepatide) vs Ozempic (semaglutide) — full comparison of effectiveness, side effects, cost, and who should use which. Updated January 2026.
Key Takeaways
- Mounjaro produces 20–22% weight loss vs Ozempic's 15–17% — significantly more
- Mounjaro targets both GLP-1 and GIP receptors — Ozempic only GLP-1
- Mounjaro (Zepbound) is now FDA and MHRA approved for obesity treatment
- Both drugs cause weight regain when stopped — ongoing treatment likely needed
- Mounjaro currently costs more and has more limited NHS availability than Ozempic
What Are These Drugs?
Both Mounjaro (tirzepatide) and Ozempic (semaglutide) are injectable medications originally developed for Type 2 diabetes that have revolutionised obesity treatment. They work by mimicking gut hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity.
22%
Average weight loss with Mounjaro 15mg (SURMOUNT-1)
15–17%
Average weight loss with Ozempic/Wegovy 2.4mg (STEP-1)
2
Hormone receptors targeted by Mounjaro vs 1 by Ozempic
Head-to-Head Comparison
| Feature | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) |
|---|---|---|
| Mechanism | Dual GLP-1 + GIP agonist | GLP-1 agonist only |
| Weight loss (obesity) | 20–22% body weight | 15–17% body weight |
| HbA1c reduction | 2.1–2.3% | 1.5–1.8% |
| Injection frequency | Once weekly | Once weekly |
| Diabetes approval | Yes (Mounjaro) | Yes (Ozempic) |
| Obesity approval | Yes (Zepbound/Mounjaro UK) | Yes (Wegovy) |
| NHS availability | Limited — specialist only | Limited — specialist only |
| CVD evidence | SURMOUNT-MMO ongoing | SELECT trial: 20% CVD reduction |
| Cost (private, monthly) | £200–350 | £180–280 |
Why Mounjaro Produces More Weight Loss
Mounjaro (tirzepatide) is a dual agonist — it activates both GLP-1 receptors (like Ozempic) AND GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism produces additive effects on appetite suppression, glucose control, and fat metabolism. The SURMOUNT-1 trial of Mounjaro 15mg showed average weight loss of 22.5% — the highest of any approved medication to date.
Side Effects — What to Expect
Common to Both
- Nausea (most common — typically 4–8 weeks, then improves)
- Vomiting and diarrhoea
- Constipation
- Reduced appetite (a desired effect)
Mounjaro-Specific Notes
Mounjaro has similar GI side effects to Ozempic but some studies suggest slightly higher initial nausea rates. Both use a slow dose-escalation protocol (starting at lowest dose) to minimise side effects.
ℹ️ Which Should You Choose?
If you have Type 2 diabetes and cardiovascular disease: Ozempic has more robust cardiovascular outcome data (SELECT trial). If maximum weight loss is the primary goal: Mounjaro produces significantly more weight loss. Both require specialist prescription in the UK/USA. Discuss with your diabetes physician or obesity specialist.🔢 Free Tool
Diabetes Risk Calculator
Get personalised results based on your own data.
Open Free Calculator →Frequently Asked Questions
Is Mounjaro available on the NHS?▼
Mounjaro was approved by NICE in 2024 for weight management in people with BMI ≥35 + weight-related comorbidities, via specialist weight management services. Like Wegovy, access remains restricted due to high demand and supply constraints. Check the NHS website for current eligibility and referral pathways.
Can I take Mounjaro without having diabetes?▼
Mounjaro/Zepbound is approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition — without requiring a diabetes diagnosis. This is the same indication as Wegovy. It does not require a diabetes diagnosis.
What happens when you stop taking Mounjaro or Ozempic?▼
Both drugs treat obesity as a chronic condition — not a short-term fix. The STEP 4 trial showed participants regained approximately 65% of lost weight within 1 year of stopping semaglutide. Similar results are seen with tirzepatide. Ongoing treatment is typically required to maintain weight loss.
Related Health Guides
Article
Ozempic — Complete Guide
Article
How to Reduce Visceral Fat
Article
Insulin Resistance Diet
Calculator
Diabetes Risk
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any medication or treatment.
Dr
Dr. Priya Sharma, MD
WellCalc Medical Contributor
All articles reviewed by qualified healthcare professionals following NHS, AHA, and WHO guidelines.